Efficacy and Safety of Ivermectin 1% Topical Cream Associated With Brimonidine 0.33% Topical Gel in the Treatment of Moderate to Severe Rosacea
Phase of Trial: Phase IV
Latest Information Update: 11 Sep 2017
At a glance
- Drugs Brimonidine (Primary) ; Ivermectin (Primary)
- Indications Rosacea
- Focus Therapeutic Use
- Acronyms MOSAIC
- Sponsors Galderma
- 11 Sep 2017 Results from this trial have been published in the Journal of Drugs in Dermatology, according to a Galderma media release.
- 13 Jan 2017 Status changed from active, no longer recruiting to completed.
- 17 Jun 2016 Planned End Date changed from 1 Jun 2016 to 1 Sep 2016.